Second Case of Tumors Associated With Heterozygous NTHL1 Variant

Cureus. 2022 Jul 11;14(7):e26734. doi: 10.7759/cureus.26734. eCollection 2022 Jul.

Abstract

Homozygous mutations to NTHL1 are known to increase cancer risk, particularly in the colon and breast. NTHL1 tumor syndrome (NTS) is an autosomal recessive genetic condition. Little is known about the cancer risk in patients who have heterozygous NTHL1 mutations. We previously published a case of benign tumors associated with a heterozygous NTHL1 mutation. In this second case, we present a patient with a heterozygous NTHL1 mutation who developed a gastrointestinal stromal tumor, pilocytic astrocytoma, tall cell papillary thyroid cancer, invasive ductal papilloma, spinal nerve sheath tumors, and spinal hemangiomas. Here, we show that heterozygous NTHL1 mutations may increase cancer risk and may even manifest similarly to NTS.

Keywords: gastrointestinal stromal tumor (gist); heterozygous; invasive ductal cell carcinoma; meningioma; nthl1; nthl1 tumor syndrome; papillary carcinoma of thyroid; pilocytic astrocytoma.

Publication types

  • Case Reports